Evidence map›Paper›PMID 31963890›Full record

ArticleCancers2020

Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk Stratification.

Giovanni Tallini, Antonio De Leo, Andrea Repaci, Dario de Biase, Maria Letizia Bacchi Reggiani, Doriana Di Nanni, Francesca Ambrosi, Cira Di Gioia, Giorgio Grani, Kerry Jane Rhoden and 4 more

Abstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Association of BRAFInternational journal of molecular sciences · 2022
    Pooled it
  2. Article
  3. Article
  4. Association BetweenCancers · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Expanding the Spectrum ofInternational journal of molecular sciences · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Giovanni TalliniDepartment of Experimental, Diagnostic and Specialty Medicine, University of Bologna-Molecular Diagnostic Unit, 40138 Azienda USL di Bologna, Italy.
Antonio De LeoPathology Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, S. Orsola-Malpighi Hospital, 40138 Bologna, Italy.
Andrea RepaciEndocrinology Unit, Department of Medical and Surgical Sciences, University of Bologna, S. Orsola-Malpighi Hospital, 40138 Bologna, Italy.
Dario de BiaseDepartment of Pharmacy and Biotechnology, University of Bologna-Molecular Diagnostic Unit, Azienda USL di Bologna, University of Bologna, 40138 Bologna, Italy.
Maria Letizia Bacchi ReggianiDepartment of Experimental, Diagnostic and Specialty Medicine, University of Bologna, S. Orsola-Malpighi Hospital, 40138 Bologna, Italy.
Doriana Di NanniDepartment of Experimental, Diagnostic and Specialty Medicine, University of Bologna-Molecular Diagnostic Unit, 40138 Azienda USL di Bologna, Italy.
Francesca AmbrosiDepartment of Experimental, Diagnostic and Specialty Medicine, University of Bologna-Molecular Diagnostic Unit, 40138 Azienda USL di Bologna, Italy.
Cira Di GioiaDepartment of Radiological, Oncological and Pathological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Giorgio GraniDepartment of Translational and Precision Medicine, "Sapienza" University of Rome, Rome 00185, Italy.
Kerry Jane RhodenGenetics Unit, Department of Medical and Surgical Sciences, University of Bologna, S. Orsola-Malpighi Hospital, 40138 Bologna, Italy.
Erica SolaroliEndocrinology Unit, Ospedale Maggiore, 40133 Bologna, Italy.
Fabio MonariRadiation Therapy Unit, S. Orsola-Malpighi Hospital, 40138 Bologna, Italy.
Sebastiano FilettiDepartment of Translational and Precision Medicine, "Sapienza" University of Rome, Rome 00185, Italy.
Cosimo DuranteDepartment of Translational and Precision Medicine, "Sapienza" University of Rome, Rome 00185, Italy.

Funding

Ministero della Salute RF-2011-02350857
6 · The paper itself

Abstract

It is unclear whether the site of origin of papillary thyroid microcarcinoma (mPTC) with respect to the thyroid surface has an influence on clinicopathologic parameters. The objectives of the study were to: (i) Accurately measure the mPTC distance from the thyroid surface; (ii) analyze whether this distance correlates with relevant clinicopathologic parameters; and (iii) investigate the impact of the site of origin of the mPTC on risk stratification. Clinicopathologic features and

Indexed as

papillary carcinoma prognosispapillary microcarcinomarisk stratificationthyroid capsulethyroid noduletumor diametertumor locationtumor origin

Identifiers

PMID31963890
PMCPMC7016743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.